Skip to main content

Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study.

Publication ,  Journal Article
Goldstein, LB; Amarenco, P; Lamonte, M; Gilbert, S; Messig, M; Callahan, A; Hennerici, M; Sillesen, H; Welch, KMA; SPARCL Investigators,
Published in: Stroke
September 2008

BACKGROUND AND PURPOSE: In SPARCL, treatment with atorvastatin 80 mg daily reduced stroke risk in patients with recent stroke or TIA and no known coronary heart disease by 16% versus placebo over 4.9 years of follow-up. The purpose of this secondary analysis was to determine whether men and women similarly benefited from randomization to statin treatment. METHODS: The effect of sex on treatment-related reductions in stroke and other cardiovascular outcomes were analyzed with Cox regression modeling testing for sex by treatment interactions. RESULTS: Women (n=1908) constituted 40% of the SPARCL study population. At baseline, men (n=2823) were younger (62.0+/-0.21 versus 63.9+/-0.27 years), had lower systolic BPs (138.1+/-0.35 versus 139.5+/-0.47 mm Hg), higher diastolic BPs (82.2+/-0.20 versus 81.0+/-0.25 mm Hg), more frequently had a history of smoking (73% versus 38%), and had lower total cholesterol (207.0+/-0.54 versus 218.9+/-0.67 mg/dL) and LDL-C levels (132+/-0.45 versus 134+/-0.57 mg/dL) than women. Use of antithrombotics and antihypertensives were similar. After prespecified adjustment for region, entry event, time since event, and age, there were no sex by treatment interactions for the combined risk of nonfatal and fatal stroke (treatment Hazard Ratio, HR=0.84, 95% CI 0.68, 1.02 in men versus HR=0.84, 95% CI 0.63, 1.11 in women; treatment x sex interaction P=0.99), major cardiac events (HR=0.61, 95% CI 0.42, 0.87 in men versus HR=0.76, 95% CI 0.48, 1.21 in women; P=0.45), major cardiovascular events (HR=0.78, 95% CI 0.65, 0.93 in men versus HR=0.84, 95% CI 0.65, 1.07 in women; P=0.63), revascularization procedures (HR=0.50, 95% CI 0.37, 0.67 in men versus HR=0.76, 95% CI 0.46, 1.24 in women; P=0.17), or any CHD event (HR=0.54, 95% CI 0.41, 0.72 in men versus 0.67 95% CI 0.46, 0.98 in women; P=0.40). CONCLUSIONS: Stroke and other cardiovascular events are similarly reduced with atorvastatin 80 mg/d in men and women with recent stroke or TIA.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Stroke

DOI

EISSN

1524-4628

Publication Date

September 2008

Volume

39

Issue

9

Start / End Page

2444 / 2448

Location

United States

Related Subject Headings

  • Triglycerides
  • Treatment Outcome
  • Stroke
  • Sex Factors
  • Sex Characteristics
  • Reproducibility of Results
  • Pyrroles
  • Neurology & Neurosurgery
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goldstein, L. B., Amarenco, P., Lamonte, M., Gilbert, S., Messig, M., Callahan, A., … SPARCL Investigators, . (2008). Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. Stroke, 39(9), 2444–2448. https://doi.org/10.1161/STROKEAHA.107.513747
Goldstein, Larry B., Pierre Amarenco, Marian Lamonte, Steven Gilbert, Michael Messig, Alfred Callahan, Michael Hennerici, Henrik Sillesen, K Michael A. Welch, and K Michael A. SPARCL Investigators. “Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study.Stroke 39, no. 9 (September 2008): 2444–48. https://doi.org/10.1161/STROKEAHA.107.513747.
Goldstein LB, Amarenco P, Lamonte M, Gilbert S, Messig M, Callahan A, Hennerici M, Sillesen H, Welch KMA, SPARCL Investigators. Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. Stroke. 2008 Sep;39(9):2444–2448.

Published In

Stroke

DOI

EISSN

1524-4628

Publication Date

September 2008

Volume

39

Issue

9

Start / End Page

2444 / 2448

Location

United States

Related Subject Headings

  • Triglycerides
  • Treatment Outcome
  • Stroke
  • Sex Factors
  • Sex Characteristics
  • Reproducibility of Results
  • Pyrroles
  • Neurology & Neurosurgery
  • Middle Aged
  • Male